Seratrodast
Product Specifications
CAS Number
112665-43-7
Target
Reactive Oxygen Species, Ferroptosis, JNK, MDM-2/p53, COX, Prostaglandin Receptor, ROS, PPAR
Related Pathways
GPCR/G Protein, NF-κB, Neuroscience, MAPK, Metabolism, DNA Damage/DNA Repair, Immunology/Inflammation, Apoptosis
Purity
0.9969
Bioactivity
Seratrodast (ABT-001) (INN), a thromboxane A2 (TXA2) receptor (TP receptor) antagonist, is mainly used in the therapy of asthma. It was the first TP receptor antagonist developed as an anti-asthmatic drug and attained marketing qualification in Japan in 1997.
Smiles
C(CCCCCC(O)=O)(C1=C(C)C(=O)C(C)=C(C)C1=O)C2=CC=CC=C2
Molecular Formula
C22H26O4
Molecular Weight
354.44
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV640837 1.0 µg DNA
CIITA Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details U4101-26B-PE 200 µL
USP26, CT (Ubiquitin Carboxyl-terminal Hydrolase 26, Ubiquitin Thiolesterase 26, Ubiquitin-specific processing Protease 26, Deubiquitinating Enzyme 26) (PE) discontinued
Sign In for Pricing
View Details